Weight gain is a common side-effect of medications used to treat major depressive disorder
(MDD). We sought to estimate the frequency of weight gain for obesogenic medications …

Objective: Weight gain during psychopharmacologic treatment has considerable impact on
the clinical management of depression, treatment continuation, and risk for metabolic …

Importance Short-term studies suggest antidepressants are associated with modest weight
gain but little is known about longer-term effects and differences between individual …

Weight gain occurs with most antidepressants but is frequently overlooked, perhaps
because clinicians are focused instead on metabolic effects of antipsychotics and mood …

Background: Weight gain as an adverse effect of monotherapy of antidepressant has been
well-studied. The effects of augmentation therapy involving multiple antidepressants, on …

Background Patients with depression and comorbid obesity may be more prone to weight
modulating and cardiovascular side effects of selected antidepressants (AD). It is important …

T he consequence of depression to individuals, families, and society is substantial.
Depression is not only a psychiatric disease, but is also one that affects physical well-being …

Background Depression and obesity are debilitating conditions representing an enormous
health and economic burden worldwide. Depression is common among patients with excess …

A majority of psychiatric medications are known to generate weight gain and ultimately
obesity in some patients. There is much speculation about the prevalence of weight gain …

A majority of psychiatric medications are known to generate weight gain and ultimately
obesity in some patients. There is much speculation about the prevalence of weight gain …